Back to Search
VICTORIA LEVIN, MD
MD
Pediatrics Physician
NPI: 1528170180Individual
Specialties, Licenses & Credentials
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
C1-0003698(DE)
Research & Publications (20)
Impact of phase II trials with progression-free survival as end-points on survival-based phase III studies in patients with anaplastic gliomas.
PMID 17587447·BMC Cancer·2007
3-trial
Relationship between ornithine decarboxylase levels in anaplastic gliomas and progression-free survival in patients treated with DFMO-PCV chemotherapy.
PMID 17582600·Int J Cancer·2007
8-other
Randomized, double-blind, placebo-controlled trial of marimastat in glioblastoma multiforme patients following surgery and irradiation.
PMID 16636750·J Neurooncol·2006
4-observational
Combination chemotherapy with 13-cis-retinoic acid and celecoxib in the treatment of glioblastoma multiforme.
PMID 16391896·J Neurooncol·2006
3-trial
Tissue-based assay for ornithine decarboxylase to identify patients likely to respond to difluoromethylornithine.
PMID 15505341·J Histochem Cytochem·2004
7-preclinical
Phase III randomized study of postradiotherapy chemotherapy with combination alpha-difluoromethylornithine-PCV versus PCV for anaplastic gliomas.
PMID 12631596·Clin Cancer Res·2003
3-trial
Phase II study of accelerated fractionation radiation therapy with carboplatin followed by PCV chemotherapy for the treatment of anaplastic gliomas.
PMID 12007942·Int J Radiat Oncol Biol Phys·2002
3-trial
Radiotherapy services in countries in transition: gross national income per capita as a significant factor.
PMID 12063003·Radiother Oncol·2002
8-other
Phase II study of 6-thioguanine, procarbazine, dibromodulcitol, lomustine, and vincristine chemotherapy with radiotherapy for treating malignant glioma in children.
PMID 11302250·Neuro Oncol·2000
3-trial
Phase III randomized study of postradiotherapy chemotherapy with alpha-difluoromethylornithine-procarbazine, N-(2-chloroethyl)-N'-cyclohexyl-N-nitrosurea, vincristine (DFMO-PCV) versus PCV for glioblastoma multiforme.
PMID 11051233·Clin Cancer Res·2000
3-trial
Two phase II trials of temozolomide with interferon-alpha2b (pegylated and non-pegylated) in patients with recurrent glioblastoma multiforme.
PMID 19672263·Br J Cancer·2009
3-trial
Displacive phase transitions at large strains: phase-field theory and simulations.
PMID 19659221·Phys Rev Lett·2009
8-other
Melding a New 3-Dimensional Agarose Colony Assay with the E(max) Model to Determine the Effects of Drug Combinations on Cancer Cells.
PMID 19334798·Technol Cancer Res Treat·2009
8-other
A new preclinical 3-dimensional agarose colony formation assay.
PMID 18642971·Technol Cancer Res Treat·2008
8-other
Phase II study of carboplatin and erlotinib (Tarceva, OSI-774) in patients with recurrent glioblastoma.
PMID 18581057·J Neurooncol·2008
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 4735 OGLETOWN STANTON RD, M.A.P. #2, SUITE 1116
NEWARK, DE 19713 - Phone
- (302) 368-8653
Quick Facts
- NPI
- 1528170180
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile